GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE344nnn/GSE344362/primaryOK200TranscriptomicsHomo sapiensExpression profiling by arrayhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE344362GEOGSEfalseGene expression profiling of Venetoclax-treated HL-60 cellsVenetoclax is a selective BCL-2 inhibitor with antileukemic activity. To investigate the transcriptional alterations induced by Venetoclax in human acute myeloid leukemia cells, HL-60 cells were treated with Venetoclax for 48 h and subjected to whole-transcriptome expression profiling using the GeneChip PrimeView Human Gene Expression Array. HL-60 cells were treated with 9.788 μM Venetoclax for 48 h. HL-60 cells without Venetoclax treatment were used as controls. Total RNA was isolated from control and Venetoclax-treated cells, and biotin-labeled cRNA was prepared and hybridized to PrimeView Human Gene Expression Array chips.2026/08/24GSE344362GSM9976572GSM9976573GSM9976574GSM9976575GSM9976576GSM997657123159344362Homo sapiens